Live oral attenuated Shigella sonnei vaccine (NIAID, WRSs3)
志贺菌减毒活疫苗（NIAID，WRSs3）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameLive oral attenuated Shigella sonnei vaccine (NIAID, WRSs3)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Walter Reed Army Institute Of Research
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWalter Reed Army Institute Of ResearchNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A